Accessibility

Data & Resources

Data Projects to Deliver Practical Tools for Alberta Producers

Seven new projects will use genomics data, AI and advanced analytics to improve livestock productivity, manage crop disease and pests, support pollinator health and strengthen antimicrobial resistance surveillance.   Calgary, Alberta – September 28, 2026 – Genome Alberta, with support from the Government of Alberta, is pleased to announce seven new projects with a total

Data Projects to Deliver Practical Tools for Alberta Producers Read More »

Graphic saying "New Work Placement Programs Announced"

Genome Alberta to Advance Innovation Through Work Placements at Biotech Companies

Edmonton, Alberta – September 24, 2026 – Today, the Government of Alberta announced an additional $1 million investment from 2026-2029 for Genome Alberta’s work placement programs. This investment will create new roles for skilled talent at 18-20 Alberta small and medium-sized businesses to develop and scale new genomics technologies. Alberta has a rapidly expanding life sciences

Genome Alberta to Advance Innovation Through Work Placements at Biotech Companies Read More »

Header design for including Metabolomix's logo

From Discovery to Market IV: Metabolomix

From Molecules to Meaning: Metabolomix Is Redefining What We Can Measure, and Why It Matters   In laboratories around the world, a quiet shift is underway. For decades, genomics has dominated life sciences research, decoding the blueprint of life. But increasingly, scientists are asking a more immediate question: what is actually happening inside biological systems

From Discovery to Market IV: Metabolomix Read More »

From Discovery to Market III: Rapid Infection Diagnostics Inc.

The Commercialization Gap Is Real: Rapid Infection Diagnostics Shows Why Early Investment Matters   For most startups, securing enough capital to move from research to commercialization is one of the greatest challenges they will face. For Alberta-based Rapid Infection Diagnostics Inc. (RID), that journey has taken more than a decade, required nearly $20 million in

From Discovery to Market III: Rapid Infection Diagnostics Inc. Read More »

Connecting New Business Grads With Genomics Innovators

Genomic tools and technologies have the potential to improve our health, environment and nutrition, and Alberta has no shortage of entrepreneurs ready to meet the challenge. However, while biotech startups are typically well-equipped to test and refine their technologies and products, scaling-up into a sustainable business presents a wholly new challenge. A 2025 survey conducted

Connecting New Business Grads With Genomics Innovators Read More »

From Discovery to Market II: Nova Medical Testing Inc.

From Lab Discovery to Global Impact: How Nova Medical Testing Inc. is Advancing Metabolomics in Alberta and Beyond   In the world of life sciences, timing is everything. While genomics can help predict what might happen in the body, metabolomics reveals what has already happened and provides a powerful perspective that is becoming increasingly important

From Discovery to Market II: Nova Medical Testing Inc. Read More »

From Discovery to Market I: Luminous BioSolutions Inc.

Lighting the Way: A Calgary Startup Tackles One of Canada’s Biggest Environmental Challenges   In northern Alberta, one of the most complex environmental challenges in the world continues to grow quietly but persistently. More than a trillion litres of oil sands tailings water sit across vast landscapes, awaiting a viable path to treatment and eventual

From Discovery to Market I: Luminous BioSolutions Inc. Read More »

From Discovery to Market: Alberta Life Sciences Companies Creating Real Value

Alberta is in the midst of a transformation. Alongside the oil sands and the agricultural industries that have long defined its economy, a new sector is taking shape: a growing life sciences industry that is converting university research into patented technologies, commercialized products, and competitive companies with global reach. The numbers tell a compelling story,

From Discovery to Market: Alberta Life Sciences Companies Creating Real Value Read More »

David Bailey, President and CEO, Genome Alberta; Rob Annan, President and CEO, Genome Canada; Karim Bardeesy, Parliamentary Secretary to the Minister of Industry, holding a sign that says "Canadian Genomics Strategy" and smiling at the camera.

Canada Invests in Genomics R&D to Accelerate Industry Growth and Technology Adoption

Federal investment through Genome Canada and the regional Genome Centres helps Canadian companies use genomics and biotech innovation to grow while unlocking private sector co-investment in research and development (R&D). March 18, 2026 — Today, on behalf of the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions,

Canada Invests in Genomics R&D to Accelerate Industry Growth and Technology Adoption Read More »

Image on the left: Dr. David Wishart giving a speech at the podium. Image on the right: Dr. Wishart posing with the award with Gijs Gijs van Rooijen, Chief Scientific Officer, Genome Alberta

ASTech Award Honours Dr. David Wishart for World-Leading Contributions in AI/ML Innovation

As data becomes the engine driving modern discovery, Dr. David Wishart stands at the forefront in building the datasets and AI tools that use information to power innovation. A globally recognized leader in metabolomics and precision health, Dr. Wishart was honoured with the ASTech Award in the AI/ML Advancement and Application category, for his groundbreaking

ASTech Award Honours Dr. David Wishart for World-Leading Contributions in AI/ML Innovation Read More »

Scroll to Top
Share
Copy Link